Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization
Conditions: Japanese Encephalitis Sponsors: Liaoning Chengda Biotechnology CO., LTD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan
Conditions: Sepsis; Disseminated Intravascular Coagulation Interventions: Other: No study intervention Sponsors: Bayer Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants
Conditions: Healthy Participants Interventions: Drug: AZD6793; Drug: AZD6793; Drug: Placebo Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
Conditions: Chronic Lymphocytic Leukemia Sponsors: AbbVie Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension
Conditions: Pulmonary Hypertension Interventions: Behavioral: tele-rehabilitation training; Behavioral: health propaganda and education Sponsors: China-Japan Friendship Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics
Conditions: Pulmonary Embolism Interventions: Drug: Rivaroxaban Sponsors: Peking Union Medical College Hospital; Ruijin Hospital; Xiangya Hospital of Central South University; China-Japan Friendship Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage Interventions: Drug: HUFF-01 Sponsors: Hokkaido University Hospital; Japan Agency for Medical Research and Development Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of Endobronchial Valve for Bronchoscopic Lung Volume Reduction Surgery: A Prospective Pilot Study
Conditions: Emphysema; Chronic Obstructive Pulmonary Disease Interventions: Procedure: bronchoscopic lung volume reduction surgery using endobronchial valve Sponsors: China-Japan Friendship Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
Conditions: Healthy Interventions: Behavioral: Group 1 (I x S x S x F); Behavioral: Group 2 (O x S x S x F); Behavioral: Group 3 (I x E x S x F); Behavioral: Group 4 (O x E x S x F); Behavioral: Group 5 (I x S x S x M); Behavioral: Group 6 (O x S x S x M); Behavioral: Group 7 (I x E x S x M); Behavioral: Group 8 (O x E x S x M); Behavioral: Group 9 (I x S x D x F); Behavioral: Group 10 (O x S x D x F); Behavioral: Group 11 (I x E x D x F); Behavioral: Group 12 (O x E x D x F); Behavioral: Group 13 (I x S x D x M); Behavioral: Group 14 (O x S x D x M); Behavioral: Group 15 (I x E x D x M); Behavioral: Group 16 (O x E x D x ...
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Establishment of Precise Nutrition Management Scheme for Patients With Prediabetes Based on Nutrigenomics
Conditions: Prediabetes Interventions: Behavioral: Precise nutritional intervention; Behavioral: Conventional nutritional intervention Sponsors: China-Japan Friendship Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Zephyr Valve Japan Post-Marketing Surveillance
Conditions: Emphysema; COPD; Severe Emphysema Interventions: Device: Zephyr Endobronchial Valve Sponsors: Pulmonx Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
Conditions: Japanese Encephalitis; Measles; Mumps; Rubella Interventions: Biological: Vero cell-drived inactive Japanese encephalitis vaccine; Biological: Measles-Mumps-Rubella Vaccine Sponsors: Liaoning Chengda Biotechnology CO., LTD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin
Conditions: Healthy Interventions: Drug: PF-07054894 or placebo Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Otsuka Announces Interim Data from Phase 2b/c Trial Indicating New Investigational Compound May Shorten Tuberculosis Treatment
Princeton, N.J. and Tokyo, Japan– March 21, 2024– Otsuka Pharmaceutical Development& Commercialization, Inc., and our parent company Otsuka Pharmaceutical, Co. Ltd., announce that interim data from a Phase 2b/c trial exploring... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 21, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer
Conditions: Carcinoma Interventions: Biological: Dostarlimab; Drug: Carboplatin; Drug: Paclitaxel Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
